These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 8558020

  • 1. Requirement for phosphatidylinositol 3'-kinase to protect hemopoietic progenitors against apoptosis depends upon the extracellular survival factor.
    Minshall C, Arkins S, Freund GG, Kelley KW.
    J Immunol; 1996 Feb 01; 156(3):939-47. PubMed ID: 8558020
    [Abstract] [Full Text] [Related]

  • 2. Phosphatidylinositol 3'-kinase, but not S6-kinase, is required for insulin-like growth factor-I and IL-4 to maintain expression of Bcl-2 and promote survival of myeloid progenitors.
    Minshall C, Arkins S, Dantzer R, Freund GG, Kelley KW.
    J Immunol; 1999 Apr 15; 162(8):4542-9. PubMed ID: 10201993
    [Abstract] [Full Text] [Related]

  • 3. Phosphatidylinositol 3-kinase (PI-3K)/Akt but not PI-3K/p70 S6 kinase signaling mediates IGF-1-promoted lens epithelial cell survival.
    Chandrasekher G, Sailaja D.
    Invest Ophthalmol Vis Sci; 2004 Oct 15; 45(10):3577-88. PubMed ID: 15452065
    [Abstract] [Full Text] [Related]

  • 4. IL-4 and insulin-like growth factor-I inhibit the decline in Bcl-2 and promote the survival of IL-3-deprived myeloid progenitors.
    Minshall C, Arkins S, Straza J, Conners J, Dantzer R, Freund GG, Kelley KW.
    J Immunol; 1997 Aug 01; 159(3):1225-32. PubMed ID: 9233617
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Phosphatidylinositol 3-kinase is essential for kit ligand-mediated survival, whereas interleukin-3 and flt3 ligand induce expression of antiapoptotic Bcl-2 family genes.
    Karlsson R, Engström M, Jönsson M, Karlberg P, Pronk CJ, Richter J, Jönsson JI.
    J Leukoc Biol; 2003 Nov 01; 74(5):923-31. PubMed ID: 12960281
    [Abstract] [Full Text] [Related]

  • 7. Insulin-like growth factor-I protects colon cancer cells from death factor-induced apoptosis by potentiating tumor necrosis factor alpha-induced mitogen-activated protein kinase and nuclear factor kappaB signaling pathways.
    Remacle-Bonnet MM, Garrouste FL, Heller S, André F, Marvaldi JL, Pommier GJ.
    Cancer Res; 2000 Apr 01; 60(7):2007-17. PubMed ID: 10766192
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Growth factor-dependent survival of rodent fibroblasts requires phosphatidylinositol 3-kinase but is independent of pp70S6K activity.
    Yao R, Cooper GM.
    Oncogene; 1996 Jul 18; 13(2):343-51. PubMed ID: 8710373
    [Abstract] [Full Text] [Related]

  • 10. IGF-1 protects oligodendrocyte progenitors against TNFalpha-induced damage by activation of PI3K/Akt and interruption of the mitochondrial apoptotic pathway.
    Pang Y, Zheng B, Fan LW, Rhodes PG, Cai Z.
    Glia; 2007 Aug 15; 55(11):1099-107. PubMed ID: 17577243
    [Abstract] [Full Text] [Related]

  • 11. IL-4 protects cells from apoptosis via the insulin receptor substrate pathway and a second independent signaling pathway.
    Zamorano J, Wang HY, Wang LM, Pierce JH, Keegan AD.
    J Immunol; 1996 Dec 01; 157(11):4926-34. PubMed ID: 8943397
    [Abstract] [Full Text] [Related]

  • 12. Insulin-like growth factor-I inhibits apoptosis in IL-3-dependent hemopoietic cells.
    Rodriguez-Tarduchy G, Collins MK, García I, López-Rivas A.
    J Immunol; 1992 Jul 15; 149(2):535-40. PubMed ID: 1624800
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Increased, not decreased activation of the insulin-like growth factor (IGF) receptor signalling pathway during ceramide-induced apoptosis.
    Stewart CE, Newcomb PV, Savage PB, Dickens M, Tavare J, Holly JM.
    Growth Horm IGF Res; 1999 Apr 15; 9(2):131-42. PubMed ID: 10373346
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. IL-3 and IL-4 activate cyclic nucleotide phosphodiesterases 3 (PDE3) and 4 (PDE4) by different mechanisms in FDCP2 myeloid cells.
    Ahmad F, Gao G, Wang LM, Landstrom TR, Degerman E, Pierce JH, Manganiello VC.
    J Immunol; 1999 Apr 15; 162(8):4864-75. PubMed ID: 10202031
    [Abstract] [Full Text] [Related]

  • 17. Raf-1 protein is required for growth factor-induced proliferation of primitive hematopoietic progenitors stimulated with synergistic combinations of cytokines.
    Muszynski KW, Ruscetti FW, Gooya JM, Linnekin DM, Keller JR.
    Stem Cells; 1997 Apr 15; 15(1):63-72. PubMed ID: 9007224
    [Abstract] [Full Text] [Related]

  • 18. Restorative effect of IL-3 on adherence of cloned hemopoietic progenitor cell to stromal cell.
    Minguell JJ, Hardy CL.
    Exp Hematol; 1993 Jan 15; 21(1):55-60. PubMed ID: 8417960
    [Abstract] [Full Text] [Related]

  • 19. Insulin and IGF-I receptors signaling in protection from apoptosis.
    Prisco M, Romano G, Peruzzi F, Valentinis B, Baserga R.
    Horm Metab Res; 1999 Jan 15; 31(2-3):80-9. PubMed ID: 10226786
    [Abstract] [Full Text] [Related]

  • 20. Insulin-like growth factor-I and the cytokines IL-3 and IL-4 promote survival of progenitor myeloid cells by different mechanisms.
    Burgess W, Jesse K, Tang Q, Broussard SR, Dantzer R, Kelley KW.
    J Neuroimmunol; 2003 Feb 15; 135(1-2):82-90. PubMed ID: 12576227
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.